Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. was formerly known as Yichang Changjiang Pharmaceutical Co., Ltd. (hereinafter referred to as "Dongyangguang Pharmaceutical" and "Company") and was established on August 8, 2001 and was restructured into a joint stock company in 2015.

Dongyangguang Pharmaceutical is a Chinese pharmaceutical company focusing on the development, production and sales of antiviral, endocrine and metabolic diseases, cardiovascular diseases and other therapeutic fields. It produces, promotes and sells a total of 33 pharmaceutical products in China and has established it in China. Large product distribution network.

In March 2006, the licensor of oseltamivir phosphate will grant Shenzhen Dongyangguang Industrial, one of our controlling shareholders, the right to sell oseltamivir phosphate to China and to institutions controlled by the Chinese government. Shenzhen Dongyangguang Industrial also has the right to license the agreement to the company. In the future, the company independently developed oseltamivir phosphate granules for the domestic pediatric patient market and obtained relevant production patents. It is a manufacturer of oseltamivir phosphate granules, thus consolidating its important position in China's anti-influenza virus product market.

The company can give priority to obtaining products developed by Yichang Dongyang Sunshine Pharmaceutical Research and Development and its subsidiaries. In terms of the number of patents submitted in China, Yichang Dongyang Sunshine Pharmaceutical R&D and its subsidiary are China's leading drug research institutions with more than [1,200] R&D personnel. Yichang Dongyang Sun Pharmaceutical Research and Development also has a large number of research projects that cooperate with overseas research cooperation institutions and major universities in the Chinese region.

Most of the company's directors and senior management team members have professional qualifications or hold important positions in industry associations, such as practicing pharmacists, professors and lecturers from several universities in China, registered auditors and executive directors of Hubei Pharmaceutical Industry Association.